Extract from the Register of European Patents

EP About this file: EP4122946

EP4122946 - ADENO-ASSOCIATED VIRUS VECTOR AND USE THEREOF [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  13.12.2024
Database last updated on 21.03.2026
FormerRequest for examination was made
Status updated on  23.12.2022
FormerThe international publication has been made
Status updated on  17.09.2021
Most recent event   Tooltip13.12.2024Withdrawal of applicationpublished on 15.01.2025  [2025/03]
Applicant(s)For all designated states
HuidaGene Therapeutics Co., Ltd.
Floor 6, Building 5-3
No. 160 Basheng Road
Pudong District
Shanghai 200131 / CN
[2023/42]
Former [2023/04]For all designated states
Huigene Therapeutics Co., Ltd.
Room 1002, Unit 1, Building No. 7
No. 160 Basheng Road
China (shanghai) Pilot Free Trade Zone
Pudong New District
Shanghai 200131 / CN
Inventor(s)01 / YAO, Xuan
Room 1002, Unit 1, Building No. 7, No. 160
Basheng Road, China (shanghai) Pilot Free Trade
Zone, Pudong New District
Shanghai 200131 / CN
02 / SHI, Linyu
Room 1002, Unit 1, Building No. 7, No. 160
Basheng Road, China (shanghai) Pilot Free Trade
Zone, Pudong New District
Shanghai 200131 / CN
03 / WANG, Shaoran
Room 1002, Unit 1, Building No. 7, No. 160
Basheng Road, China (shanghai) Pilot Free Trade
Zone, Pudong New District
Shanghai 200131 / CN
04 / BAI, Weiya
Room 1002, Unit 1, Building No. 7, No. 160
Basheng Road, China (Shanghai) Pilot Free Trade
Zone, Pudong New District
Shanghai 200131 / CN
 [2023/04]
Representative(s)Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[2023/04]
Application number, filing date21767492.804.02.2021
[2023/04]
WO2021CN75213
Priority number, dateCN20201017773913.03.2020         Original published format: CN202010177739
[2023/04]
Filing languageZH
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021179861
Date:16.09.2021
Language:ZH
[2021/37]
Type: A1 Application with search report 
No.:EP4122946
Date:25.01.2023
Language:EN
[2023/04]
Search report(s)International search report - published on:CN16.09.2021
(Supplementary) European search report - dispatched on:EP12.03.2024
ClassificationIPC:C07K14/015, C12N15/35, C12N15/864, C12N7/01, A61K48/00, A61P27/16
[2023/04]
CPC:
C07K14/705 (EP); C07K14/005 (EP,CN,US); C12N15/86 (EP,CN,US);
A61K48/0008 (CN); A61K48/0041 (EP); A61K48/005 (EP);
A61K48/0058 (US); A61K48/0075 (EP); A61P27/16 (CN,US);
C07K14/47 (EP,CN); A61K48/0033 (EP); C12N2750/14122 (EP,CN,US);
C12N2750/14123 (CN); C12N2750/14143 (EP,CN,US); C12N2750/14145 (EP,US);
C12N2750/14171 (US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2023/04]
TitleGerman:ADENO-ASSOZIIERTER VIRUSVEKTOR UND VERWENDUNG DAVON[2023/04]
English:ADENO-ASSOCIATED VIRUS VECTOR AND USE THEREOF[2023/04]
French:VECTEUR DE VIRUS ADÉNO-ASSOCIÉ ET SON UTILISATION[2023/04]
Entry into regional phase12.10.2022Translation filed 
12.10.2022National basic fee paid 
12.10.2022Search fee paid 
12.10.2022Designation fee(s) paid 
12.10.2022Examination fee paid 
Examination procedure12.10.2022Examination requested  [2023/04]
01.10.2024Amendment by applicant (claims and/or description)
01.10.2024Date on which the examining division has become responsible
10.12.2024Application withdrawn by applicant  [2025/03]
Fees paidRenewal fee
20.02.2023Renewal fee patent year 03
20.02.2024Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[XI] WO2019221992  (HARVARD COLLEGE et al.) [X] 1,2,4,5,9-12 * paragraph [0056]; claims 1-35; tables 1, 2, 310, 11, 16; sequence 1 *[I] 6,13-15
 [A]   LAUREN M DROUIN ET AL: "Adeno-associated virus structural biology as a tool in vector development", FUTURE VIROLOGY, vol. 8, no. 12, 1 December 2013 (2013-12-01), UK, pages 1183 - 1199, XP055272409, ISSN: 1746-0794, DOI: 10.2217/fvl.13.112 [A] 1-15 * page 9, paragraph 2 *

DOI:   http://dx.doi.org/10.2217/fvl.13.112
International search[PX] CN111349148  (HUIDA SHANGHAI BIOTECHNOLOGY CO LTD et al.) [PX] 1, 2, 4-34 (in part) * see claims 1-33 *
 [A] CN110770346  (UNIV NORTH CAROLINA CHAPEL HILL et al.) [A] 1, 2, 4-34 (in part) * see entire document *
 [A] WO2019025984  (REFLECTION BIOTECHNOLOGIES LTD et al.) [A] 1, 2, 4-34 (in part) * see entire document *
 [A] CN109897831  (SUZHOU JIMAI GENE MEDICAMENT BIOTECHNOLOGY CO LTD et al.) [A] 1, 2, 4-34 (in part) * see entire document *
 [A] WO2007120542  (UNIV LELAND STANFORD JUNIOR et al.) [A] 1, 2, 4-34 (in part) * see entire document *
 [X]   YINGYING MAO: "Study on hepatitis B gene therapy based on AAV-mediated artificial miRNA", CHINESE DOCTORAL DISSERTATIONS FULL-TEXT DATABASE, UNIVERSITY OF CHINESE ACADEMY OF SCIENCES, CN, 15 February 2017 (2017-02-15), CN, pages 1 - 118, XP055751466, ISSN: 1674-022X [X] 1, 2, 4-34 (in part) * see the abstract, and pp. 9, 10, 68, 69, 74, 92 and 93 *
 [X]   YINGYING MAO, XUEJUN WANG, RENHE YAN, WEI HU, ANDREW LI, SHENGQI WANG, HONGWEI LI: "Single point mutation in adeno-associated viral vectors -DJ capsid leads to improvement for gene delivery in vivo", BMC BIOTECHNOLOGY, BIOMED CENTRAL LTD, vol. 16, no. 1, 5 October 2016 (2016-10-05), pages 1 - 8, XP055372854, ISSN: 1472-6750, DOI: 10.1186/s12896-015-0230-0 [X] 1, 2, 4-34 (in part) * see the abstract, and pp. 2-7 *

DOI:   http://dx.doi.org/10.1186/s12896-015-0230-0
by applicantCN202010177739
   NISHANTH GABRIEL ET AL., HUMAN, vol. 24, 2013, pages 80 - 93 [X] 1, 2, 4-34 (in part) * see the abstract, and pp. 2-7 *
   WU, ASOKAN ET AL., J VIROL., vol. 80, no. 22, 2006, pages 11393 - 11397
   EXCOFFON, KOERBER ET AL., PROC NATL ACAD SCI USA, vol. 106, no. 10, 2009, pages 3865 - 3870
   BLEKER, PAWLITA ET AL., J VIROL, vol. 80, no. 2, 2006, pages 810 - 820
   NEEDLEMANWUNSCH, J. MOL. BIOL., vol. 48, no. 3, 1970, pages 443 - 453
   RICE, P. ET AL.: "EMBOSS: The European Molecular Biology Open Software Suite", TRENDS IN GENETICS, vol. 16, no. 6, 2000, pages 276 - 277, XP004200114, DOI: 10.1016/S0168-9525(00)02024-2

DOI:   http://dx.doi.org/10.1016/S0168-9525(00)02024-2
   KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 87, 1990, pages 2264
   KARLINALTSCHUL, PROC. NATL. ACAD. SCI. USA, vol. 90, 1993, pages 5873 - 5877
   ALTSCHUL ET AL., J. MOL. BIOL., vol. 215, 1990, pages 403
   ALTSCHUL ET AL., NUCLEIC ACIDS RES., vol. 25, 1997, pages 3389 - 3402
   DAYHOFF ET AL.: "Atlas of Protein Sequence and Structure", vol. 5, 1978, NATL. BIOMED. RES. FOUND., article "A model of evolutionary change in proteins", pages: 345 - 352
   HENIKOFF ET AL., PROC. NATL. ACAD. SCI. USA, vol. 89, 1992, pages 10915 - 10919
   "Remington's Pharmaceutical Sciences", 1995, MACK PUBLISHING COMPANY
   GRIMM D ET AL., J VIROL, vol. 82, no. 12, June 2008 (2008-06-01), pages 5887 - 911
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.